Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.03B | 2.01B | 1.82B | 1.78B | 1.64B | 1.02B |
Gross Profit | 1.14B | 1.14B | 990.03M | 966.09M | 1.02B | 637.38M |
EBITDA | 330.05M | 398.26M | 196.91M | 138.80M | 417.65M | 245.30M |
Net Income | 144.34M | 125.88M | 33.35M | 21.16M | 281.98M | 253.97M |
Balance Sheet | ||||||
Total Assets | 2.38B | 2.43B | 2.22B | 2.20B | 2.15B | 1.75B |
Cash, Cash Equivalents and Short-Term Investments | 1.36B | 1.39B | 1.31B | 1.49B | 1.75B | 1.55B |
Total Debt | 156.00M | 175.74M | 198.28M | 176.09M | 0.00 | 0.00 |
Total Liabilities | 510.00M | 525.89M | 452.09M | 384.14M | 276.63M | 195.52M |
Stockholders Equity | 1.86B | 1.91B | 1.77B | 1.82B | 1.87B | 1.55B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 394.62M | -20.72M | -148.90M | 236.38M | 277.93M |
Operating Cash Flow | 0.00 | 409.78M | 140.71M | -24.91M | 400.24M | 295.72M |
Investing Cash Flow | 0.00 | -308.40M | -175.24M | -225.45M | -217.76M | -17.08M |
Financing Cash Flow | 0.00 | -22.05M | -140.58M | -4.74M | 14.99M | 1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥3.82B | 28.95 | ― | 10.24% | 280.31% | ||
72 Outperform | ¥4.61B | 43.02 | ― | 21.12% | 3.91% | ||
62 Neutral | £513.03M | 25.06 | -8.61% | 2.52% | 4.26% | -25.61% | |
60 Neutral | ¥4.07B | 278.21 | ― | 17.44% | ― | ||
54 Neutral | ¥4.27B | 17.07 | ― | 11.96% | -434.38% |